NelsonHandalMD

Psychiatry • Dothan, AL

Child & Adolescent Psychiatry

Physician

Join to view full profile

Dr. Handal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Handal's full profile

Already have an account?

Office
408 Healthwest Dr
Dothan, AL 36303
Phone+1 334-702-7222

Fax+1 334-702-1944

Education & Training

University of Miami/Jackson Health SystemFellowship, Child and Adolescent Psychiatry, 1994 - 1996
SUNY Upstate Medical UniversityResidency, Psychiatry, 1991 - 1994
Universidad Boliviana Mayor de San Andres Faculty of MedicineClass of 1981

Certifications & Licensure

FL State Medical License 1995 - 2025
AL State Medical License 1996 - 2024
NY State Medical License 1994 - 1996
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01
Completed
Phase 3
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30
Completed
Phase 3
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension Start of enrollment: 2019 Oct 04
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

17 citations
A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Maz...
Timothy Wigal, Jeffrey H. Newcorn, Nelson Handal, Sharon B. Wigal, Ioulietta Mulligan
CNS Drugs. 2018-03-19
1 citations
Validation, reliability, and specificity of CliniCom™ Psychiatric Assessment Software.
Nelson Handal, James P. LePage, Philip Dayley, Barbara Baldwin, Amellia Roeser
Psychiatry Research. 2018-07-01

Press Mentions

CDC: Half of People with ADHD Diagnosed in AdulthoodOctober 15th, 2024
NLS Pharma Named Winner of A Prestigous 2016 Healthcare & Life Sciences AwardDecember 2nd, 2016
We Demand Attention on Understanding Why Comorbid Conditions like Anxiety and Depression Uniquely Impact Women with ADHDMay 7th, 2024